Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

GMED 25.51 -0.26 (-1.01%)
price chart
Globus Medical, Inc. Investors Encouraged to Contact Securities Law Firm about ...
NEW YORK, April 30, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Globus Medical, Inc. shareholders GMED, +0.35% Concerned GMED investors who purchased prior to April 22, 2015 are encouraged to ...
Weekly Research Analysts' Ratings Updates for Globus Medical (GMED)
5/7/2015 - Globus Medical was upgraded by analysts at Zacks from a “hold” rating to a “buy” rating. They now have a $28.00 price target on the stock.
Globus Medical Given a $31.00 Price Target at Canaccord Genuity (GMED)  Mideast Time
Looking for a Top Growth Stock? 3 Reasons Why Globus Medical (GMED) Is an ...
One such company that stands out in this regard is undoubtedly Globus Medical, Inc. (GMED - Snapshot Report). Not only does this company have a favorable growth score, but it is ranked as a buy too.
Harwood Feffer LLP Announces Investigation of Globus Medical, Inc.
NEW YORK, April 27, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED), concerning whether the board has breached ...
Canaccord Genuity Analysts Give Globus Medical a $31.00 Price Target (GMED)
Globus Medical Inc logo Canaccord Genuity set a $31.00 price target on Globus Medical (NASDAQ:GMED) in a research note issued to investors on Wednesday.
Fri Morning Thoughts: Legg Mason Inc. (LM), Globus Medical, Inc. (GMED ...  WallStreet Scope
Analyst Views: Globus Medical, Inc. (NYSE:GMED)
Based on analyst estimates, Globus Medical, Inc. (NYSE:GMED) is expected to post current fiscal quarter earnings per share of $0.24.
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
Is there Value for Investors: Globus Medical, Inc. (NYSE:GMED)
We look at Globus Medical, Inc. (NYSE:GMED) a company in the Healthcare industry which traders have been highly interested in of late, to assess if it provides value for investors considering buying or selling it.
Analysts Evaluation on Globus Medical, Inc. (NYSE:GMED)
Wall Street Equity Research analysts evaluating future earnings growth for Globus Medical, Inc. (NYSE:GMED), are predicting that the company will report $0.25 for the quarter ending on 2015-03-31.
Globus Medical's Hold Rating Reiterated at Zacks (GMED)  The Legacy
Globus Medical, Inc. (GMED) Reports Revenue Well Above Consensus, Brean ...
Brean Capital reiterates their Buy rating on Globus Medical, Inc. (NYSE: GMED) and raised the target price to $33 (from $30) after GMED posted revenues well above consensus.
Globus Medical Inc (GMED) Updates FY15 Earnings Guidance  sleekmoney
Globus Medical Raised to Buy at Zacks (GMED)  Dakota Financial News